4.5 Review

Synthetic high-density lipoprotein nanoparticles: Good things in small packages

期刊

OCULAR SURFACE
卷 21, 期 -, 页码 19-26

出版社

ELSEVIER
DOI: 10.1016/j.jtos.2021.03.001

关键词

Chemical burn; Cholesterol; Cornea; Eye drop; Inflammation; Lipoprotein; microRNA; Nanotechnology; Wound healing

资金

  1. National Institutes of Health [EY06769, EY019463, EY028560]
  2. Dermatology Foundation
  3. Eversight research grant
  4. Prostate Cancer Foundation
  5. Center for Regenerative Nanomedicine (CRN)
  6. Nanyang Technological Institute-Northwestern University (NTU-NU) Institute for Nanomedicine
  7. Career Development Award
  8. [AR064144]
  9. [AR071168]

向作者/读者索取更多资源

Medicine has greatly benefited from the nanotechnology revolution, particularly in the development of bio-nanoparticles like synthetic high-density lipoprotein (HDL) nanoparticles for treating ocular diseases. These HDL nanoparticles mimic natural HDLs, bind with receptors, are non-toxic, and can deliver microRNAs effectively. Their translational potential in the form of topical eye drops highlights the impact nanoparticles can have in medicine.
Medicine has been a great beneficiary of the nanotechnology revolution. Nanotechnology involves the synthesis of functional materials with at least one size dimension between 1 and 100 nm. Advances in the field have enabled the synthesis of bio-nanoparticles that can interface with physiological systems to modulate fundamental cellular processes. One example of a diverse acting nanoparticle-based therapeutic is synthetic high-density lipoprotein (HDL) nanoparticles (NP), which have great potential for treating diseases of the ocular surface. Our group has developed a spherical HDL NP using a gold nanoparticle core. HDL NPs: (i) closely mimic the physical and chemical features of natural HDLs; (ii) contain apoA-I; (iii) bind with high-affinity to SR-B1, which is the major receptor through which HDL modulates cell cholesterol metabolism and controls the selective uptake of HDL cargo into cells; (iv) are non-toxic to cells and tissues; and (v) can be chemically engineered to display nearly any surface or core composition desired. With respect to the ocular surface, topical application of HDL NPs accelerates re-epithelization of the cornea following wounding, attenuates inflammation resulting from chemical burns and/or other stresses, and effectively delivers microRNAs with biological activity to corneal cells and tissues. HDL NPs will be the foundation of a new class of topical eye drops with great translational potential and exemplify the impact that nanoparticles can have in medicine.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据